Visual outcome, local tumour control, and eye preservation after 106Ru/Rh brachytherapy for choroidal melanoma

Acta Oncologica
Peter IsagerJens Overgaard

Abstract

To study the visual outcome, local tumour control, and eye preservation 5 years after ruthenium/rhodium 106 brachytherapy for choroidal melanoma. The study included 55 consecutive patients treated by 106Ru/Rh brachytherapy for a choroidal melanoma during the period 1988-2000 and followed through 2004. The 5-year probability for not losing at least 5 Snellen lines was 59% (n = 45), for retaining a visual acuity of 0.33 or better was 28% (n = 34), and for retaining better than 0.1 was 40% (n = 45). The 5-year probability for no local recurrence was 73% and for eye preservation 72% (n = 55). 106Ru/Rh brachytherapy for choroidal melanoma resulted in a clinically significant vision loss, no local recurrence, and eye preservation in most patients after 5 years. 106Ru/Rh brachytherapy can be regarded as a good treatment option for small and medium-sized tumours but not for large tumours.

References

Dec 1, 1991·The British Journal of Ophthalmology·P K Lommatzsch, R Lommatzsch
Jun 1, 1990·Ophthalmology·J M SeddonD M Albert
Sep 1, 1988·International Journal of Radiation Oncology, Biology, Physics·J E MunzenriderM M Goitein
Oct 1, 1986·International Journal of Radiation Oncology, Biology, Physics·R P MüllerU Haverkamp
Nov 1, 1986·The British Journal of Ophthalmology·P K Lommatzsch
Feb 1, 1995·American Journal of Ophthalmology·E S GragoudasV Taratuta
Aug 1, 1994·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·P K LommatzschF Rohrwacher
Oct 1, 1993·The British Journal of Ophthalmology·B E DamatoW S Foulds
Dec 1, 1993·Mayo Clinic Proceedings·J A Shields, C L Shields
Aug 1, 1993·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M KleineidamS M Bentzen
Jul 15, 1993·International Journal of Radiation Oncology, Biology, Physics·J FontanesiD Tai
Feb 1, 1996·The British Journal of Ophthalmology·B E DamatoW S Foulds
Aug 1, 1996·The British Journal of Ophthalmology·P SummanenA Tarkkanen
Jan 1, 1997·Frontiers of Radiation Therapy and Oncology·N BornfeldM H Foerster
Dec 10, 1997·International Journal of Radiation Oncology, Biology, Physics·J R CastroT L Phillips
Feb 26, 1999·Archives of Ophthalmology·K GündüzL W Brady
May 18, 1999·Archives of Ophthalmology·K GündüzL W Brady
Jul 29, 1999·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·J J AugsburgerL W Brady
Sep 7, 1999·International Journal of Radiation Oncology, Biology, Physics·A CourdiP Chauvel
Feb 9, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·R E Tjho-HeslingaJ W Leer
Apr 15, 2000·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·P K LommatzschE Schuster
Feb 13, 2001·Acta Ophthalmologica Scandinavica·S Seregard, I Landau
Jul 27, 2001·Archives of Ophthalmology·M Diener-WestUNKNOWN Collaborative Ocular Melanoma Study Group
Apr 18, 2002·International Journal of Radiation Oncology, Biology, Physics·Robert JonesBeth Erickson
Jun 8, 2002·Progress in Retinal and Eye Research·J G Journée-de Korver, J E E Keunen
Dec 10, 2002·Archives of Ophthalmology·Evangelos GragoudasKathleen M Egan
Jun 19, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Karin DieckmannRichard Pötter

❮ Previous
Next ❯

Citations

May 16, 2020·Acta Oncologica·Charlotte A EspensenJens F Kiilgaard
May 3, 2011·European Journal of Ophthalmology·Alena FurdovaPeter Slezak
Sep 4, 2020·The British Journal of Ophthalmology·Renato Jose YupariArun Singh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Australian and New Zealand Journal of Ophthalmology
F A BillsonG W Aylward
Journal of Pediatric Ophthalmology and Strabismus
L Speedwell, I Russell-Eggitt
© 2022 Meta ULC. All rights reserved